Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

49.3K
Overview
49.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Nanoparticle Vaccine Displaying Conserved Epitopes of the Preexisting Neutralizing Antibody Confers Broad Protection against SARS-CoV-2 Variants.

ACS nano·2024
Same author

An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses.

ACS nano·2023
Same author

Self-Assembling Nanovaccine Confers Complete Protection Against Zika Virus Without Causing Antibody-Dependent Enhancement.

Frontiers in immunology·2022
Same author

T-Cell Immunoglobulin and Mucin Domain 1 (TIM-1) Is a Functional Entry Factor for Tick-Borne Encephalitis Virus.

mBio·2022
Same author

Three-Fragment Fluorescence Complementation for Imaging of Ternary Complexes under Physiological Conditions.

Analytical chemistry·2018

Related Experiment Video

Updated: Nov 22, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.8K

Self-Assembled Nanoparticles: Exciting Platforms for Vaccination.

Jingdi Pan1,2, Zongqiang Cui1,2

  • 1State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.

Biotechnology Journal
|January 7, 2021
PubMed
Summary

Self-assembled nanoparticles (SANPs) offer a promising solution for vaccine development, enhancing antigen presentation and immune responses. These novel carriers show potential for needle-free vaccine delivery, improving efficacy and accessibility.

Keywords:
ferritininfluenza virusself‐assembled nanoparticlevaccinevirus‐like particle

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.8K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K

Related Experiment Videos

Last Updated: Nov 22, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.8K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.8K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K

Area of Science:

  • Nanotechnology in vaccinology
  • Immunology and vaccine development

Background:

  • Vaccination has significantly improved public health, but limitations exist for certain infectious diseases.
  • The development of safer, less immunogenic protein/peptide antigens necessitates effective delivery carriers.
  • Self-assembled nanoparticles (SANPs) are emerging as key candidates for advanced vaccine formulations.

Purpose of the Study:

  • To review the potential of self-assembled nanoparticles (SANPs) as antigen delivery carriers in vaccine development.
  • To explore the advantages of SANPs in enhancing antigen presentation and immune responses.
  • To discuss the application of SANPs in prophylactic vaccines, including needle-free delivery systems.

Main Methods:

  • Review of existing literature on self-assembled nanoparticles (SANPs) for vaccine applications.
  • Analysis of SANP characteristics, including nanoscale presentation, size, geometry, and functionality.
  • Evaluation of SANPs' ability to mimic pathogens for enhanced immunogenicity.

Main Results:

  • SANPs facilitate nanoscale, multi-antigen presentation, mimicking pathogen structures.
  • These nanoparticles enhance both cellular and humoral immunity responses.
  • SANPs exhibit adhesive properties suitable for needle-free vaccine administration.

Conclusions:

  • Self-assembled nanoparticles (SANPs) represent a significant advancement in vaccine carrier technology.
  • Their ability to enhance antigen presentation and elicit robust immune responses is highly promising.
  • SANPs hold considerable potential for the future of prophylactic vaccines, particularly with needle-free delivery.